Project Details
| Short title | DB-1303-O-3002 |
|---|---|
| Acronym | DYNASTY-Breast02 |
| Status | Active |
| Effective start/end date | 20/02/24 → 16/11/28 |
CTU: A Phase 3, Randomized, Multi-center, Open-label Study of DB-1303 Versus Investigator’s Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02).
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Contacos, Christine (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
Project: Research